[go: up one dir, main page]

DE69634662D1 - Schmerzlindernde verwendung von n-l-alpha-aspartyl-l-phenylalanine-1-methylester - Google Patents

Schmerzlindernde verwendung von n-l-alpha-aspartyl-l-phenylalanine-1-methylester

Info

Publication number
DE69634662D1
DE69634662D1 DE69634662T DE69634662T DE69634662D1 DE 69634662 D1 DE69634662 D1 DE 69634662D1 DE 69634662 T DE69634662 T DE 69634662T DE 69634662 T DE69634662 T DE 69634662T DE 69634662 D1 DE69634662 D1 DE 69634662D1
Authority
DE
Germany
Prior art keywords
aspartyl
alpha
methyl ester
personal
phenyl alanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69634662T
Other languages
English (en)
Other versions
DE69634662T2 (de
Inventor
B Edmundson
V Manion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oklahoma Medical Research Foundation
Original Assignee
Oklahoma Medical Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Medical Research Foundation filed Critical Oklahoma Medical Research Foundation
Application granted granted Critical
Publication of DE69634662D1 publication Critical patent/DE69634662D1/de
Publication of DE69634662T2 publication Critical patent/DE69634662T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seasonings (AREA)
DE69634662T 1995-06-23 1996-06-21 Schmerzlindernde verwendung von n-l-alpha-aspartyl-l-phenylalanine-1-methylester Expired - Fee Related DE69634662T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US590409 1990-09-28
US479 1993-01-05
US47995P 1995-06-23 1995-06-23
US08/590,409 US5654334A (en) 1995-06-23 1996-01-25 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
PCT/US1996/010716 WO1997000692A1 (en) 1995-06-23 1996-06-21 ANALGESIC USE OF N-L-α-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER

Publications (2)

Publication Number Publication Date
DE69634662D1 true DE69634662D1 (de) 2005-06-02
DE69634662T2 DE69634662T2 (de) 2006-03-02

Family

ID=26667704

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69634662T Expired - Fee Related DE69634662T2 (de) 1995-06-23 1996-06-21 Schmerzlindernde verwendung von n-l-alpha-aspartyl-l-phenylalanine-1-methylester

Country Status (8)

Country Link
US (2) US5654334A (de)
EP (1) EP0833651B1 (de)
JP (1) JP2000502318A (de)
AT (1) ATE293986T1 (de)
AU (1) AU722460B2 (de)
CA (1) CA2225462A1 (de)
DE (1) DE69634662T2 (de)
WO (1) WO1997000692A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
CA2266098A1 (en) * 1996-09-26 1998-04-02 Oklahoma Medical Research Foundation Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression
US6156795A (en) * 1997-12-22 2000-12-05 Oklahoma Medical Research Foundation N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its derivatives for appetite enhancement
US6326400B1 (en) 1999-08-27 2001-12-04 Allen B. Edmundson N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its derivatives for appetite enhancement
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
WO2001022983A2 (en) * 1999-09-25 2001-04-05 Oklahoma Medical Research Foundation Viscosity modulating substance and use thereof
US6919374B1 (en) 1999-09-25 2005-07-19 Oklahoma Medical Research Foundation Viscosity modulating substance and use thereof
JP2005060311A (ja) * 2003-08-13 2005-03-10 Mochida Pharmaceut Co Ltd Ｎ−（ベンゾイル）アミノ酸誘導体を有効成分とするニューロパシー性疼痛治療剤
WO2005107788A1 (en) * 2004-04-27 2005-11-17 Oklahoma Medical Research Foundation Inhibition of allergic contact dermatitis by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester
WO2005123106A1 (en) * 2004-06-10 2005-12-29 Oklahoma Medical Research Foundation Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester to treat sunburn and other burns
US20070225277A1 (en) * 2006-03-24 2007-09-27 Wyeth Treatment of pain
CA3195252A1 (en) 2013-12-24 2015-07-02 Durect Corporation Uses of oxygenated cholesterol sulfates (ocs)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3492131A (en) * 1966-04-18 1970-01-27 Searle & Co Peptide sweetening agents
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
WO1988007892A1 (en) * 1987-04-09 1988-10-20 Terumo Kabushiki Kaisha B lymphocyte separating material and body fluid clarifying material
JPH0832627B2 (ja) * 1988-02-16 1996-03-29 三井東圧化学株式会社 二日酔予防治療剤
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
FR2649611A1 (fr) * 1989-07-13 1991-01-18 Philippe Perovitch Procede de preparation galenique d'une composition therapeutique notamment a base d'aspirine
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
BE1007099A5 (fr) * 1993-11-22 1995-03-14 Messadek Jallal Activite medicamenteuse de l'aspartame.
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester

Also Published As

Publication number Publication date
JP2000502318A (ja) 2000-02-29
AU722460B2 (en) 2000-08-03
DE69634662T2 (de) 2006-03-02
EP0833651B1 (de) 2005-04-27
WO1997000692A1 (en) 1997-01-09
ATE293986T1 (de) 2005-05-15
EP0833651A1 (de) 1998-04-08
CA2225462A1 (en) 1997-01-09
AU6287896A (en) 1997-01-22
US5998473A (en) 1999-12-07
US5654334A (en) 1997-08-05

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE69634662D1 (de) Schmerzlindernde verwendung von n-l-alpha-aspartyl-l-phenylalanine-1-methylester
MX9600065A (es) Polisacaridos acidicos reticulados y sus usos.
CA2214097A1 (en) Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
GB2340039B (en) Improved delivery of drugs to mucosal surfaces
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
ATE168563T1 (de) System mit erhöhender hautpenetration für verbesserte topische verabreichung von arzneimitteln
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
BR9711671A (pt) Tratamento com ácido graxo.
SI1572167T1 (sl) Transdermalni buprenorfinski dozirni reĹľim za analgezijo
EE9900470A (et) Tsinkhüaluronaadi kasutamine peptilise haavandi vastu
TR199701520T1 (xx) Ac�n�n iyile�tirilmesi i�in analjesik bile�ikleri �reten h�cre soyu.
HK1005847A1 (en) Use of acetyl l-carnitine in the therapeutic treatment of coma
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
ITMI921556A0 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani
IL126175A0 (en) Method or treating heart failure with endothelin antagonists and pharmaceutical compositions containing the same
GEP20043252B (en) Use of NOS Inhibitors by New Pharmaceutical Designation for Treatment of Chronic and Acute Pains with Mammalians
DE60004833D1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung
NZ332688A (en) Stimulation of host defence mechanisms against tumors using interferon
EP1374873B8 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
CA2341891A1 (en) The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
Drusan et al. The granulocytopenic cancer patient. When and how to initiate empiric antimicrobial therapy.
RU92015086A (ru) Препарат для аналгезии на основе морфина
MD1296F1 (en) The Nicolau method of treatment of the lichen planus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee